Jose Del Solar Bou
CEO
BY BUG
This company develops genetically modified black soldier fly strains to create a highly efficient and sustainable biomanufacturing platform. Their technology produces a diverse range of high-quality recombinant proteins for pharmaceuticals, vaccines, and industrial enzymes. This approach offers competitive pricing while supporting responsible production and consumption goals.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$1.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Daniel Troncoso-Espinosa
CTO
Product
Problem
The production of recombinant proteins often relies on traditional methods that are expensive, environmentally unsustainable, and difficult to scale. Existing biomanufacturing processes struggle to meet the growing demand for cost-effective and sustainable bio-based products across various industries.
Solution
ByBug utilizes genetically modified black soldier fly larvae as a biomanufacturing platform to convert organic waste into high-value recombinant proteins. By engineering specific strains of black soldier flies, ByBug can produce a wide array of recombinant proteins, ranging from vaccines and pharmaceuticals to industrial enzymes, at a competitive cost. This approach offers a sustainable alternative to conventional protein production methods by leveraging insect bioconversion to reduce waste and create valuable bio-based products. The ByBug Synthetics® technology aims to establish a new standard in biomanufacturing through biotechnology and innovation.
Target Audience
ByBug's primary customers include companies in the pharmaceutical, agricultural, and industrial sectors seeking sustainable and cost-effective sources of recombinant proteins and bio-based products.
Features
- Genetically modified black soldier fly strains optimized for efficient protein production.
- Bioconversion process that transforms organic waste into recombinant proteins.
- Production of a variety of recombinant proteins for diverse industries, including pharmaceuticals, agriculture, and industrial applications.
- Sustainable and cost-effective alternative to traditional protein production methods.
- Customizable protein production services tailored to specific client needs.